// App-Quantinova.ai

281 ⋆ : Time‐dependent factors associated with diminished transplant‐free survival in patients with primary biliary cholangitis and an optimal response to ursodeoxycholic acid after one year of treatment

Researchers

Presenter

  • Willem J. Lammers

Principal Investigators

  • Marlyn J. Mayo

  • Annarosa Floreani

  • Pietro Invernizzi

  • Maren H. Harms

  • Christophe Corpechot

  • Keith D. Lindor

  • Cyriel Y. Ponsioen

  • Harry L. Janssen

  • Douglas Thorburn

  • Pier Maria Battezzati

  • Frederik Nevens

  • George Dalekos

  • Albert Pares

  • Tony Bruns

  • Andrew Mason

  • Kris V. Kowdley

  • Gideon Hirschfield

  • Xavier Verhelst

  • Bettina E. Hansen

  • Henk R. van Buuren

Medical Centers

  • Department of Gastroenterology and Hepatology, Leiden University Medical Center, Leiden, Netherlands

  • UTSouthwestern Medical Center, Dallas, TX

  • University of Pavia, Pavia, Italy

  • University of Milan, Milan, Italy

  • Hospital Saint Antoine, Paris, France

  • Arizona State University, Phoenix, AZ

  • Academic Medical Center, Amsterdam, Netherlands

  • Toronto Western Hospital, Toronto, ON, Canada

  • Sheila Sherlock Liver Unit and UCL Institute for Liver and Digestive Health, Royal Free Hospital and UCL, London, United Kingdom

  • Hospitals Leuven, KULeuven, Leuven, Belgium

  • Universita' Degli Studi di Milano, Milano, Italy.

  • University of Larissa, Larissa, Greece

  • Ghent University Hospital, Ghent, Belgium

  • Universitat de Barcelona, Barcelona, Spain

  • University of Birmingham, Birmingham, United Kingdom

  • Friedrich-Schiller-University Jena, Jena, Germany

  • University of Alberta, Edmonton, AB, Canada

  • Swedish Medical Center, Seattle, WA

Locations

  • Netherlands

  • United States

  • Italy

  • France

  • Canada

  • United Kingdom

  • Belgium

  • Greece

  • Spain

  • Germany

Companies

  • N/A

Study Components

Therapeutic Area

  • Gastroenterology (GU)

Disease

  • Primary biliary cirrhosis

Biomarkers

  • Alanine transaminase

  • Aspartate aminotransferase

  • Human albumin

Drug/Treatment

  • Alkaline phosphatase

  • Ursodeoxycholic acid

Outcome

  • N/A


Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A